Ethyl 3-((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)propanoate

Catalog No. :
ACWTAO775
CAS No. :
41355-18-4
Molecular Formula :
C14H19N5O5
Molecular Weight :
337.34

IUPAC Name:ethyl 3-((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)propanoate

Ethyl 3-((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 3-((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)propanoate
IUPAC Nameethyl 3-((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)propanoate
Molecular FormulaC14H19N5O5
Molecular Weight337.34
SMILESCCOC(=O)CC[C@H]1O[C@@H](N2C=NC3=C(N)N=CN=C32)[C@H](O)[C@@H]1O
InChI KeyDNKINXKUWXUNRF-FRJWGUMJSA-N
Synonymβ-D-ribo-Heptofuranuronic acid, 1-(6-amino-9H-purin-9-yl)-1,5,6-trideoxy-, ethyl ester (9CI);Ethyl 3-(5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)propanoate;β-D-ribo-Heptofuranuronic acid, 1-(6-amino-9H-purin-9-yl)-1,5,6-trideoxy-, ethyl ester
CAS No.41355-18-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWTAO775 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWTAO775 route product structure diagram
    ACWTAO77541355-18-4
Inquiry

2. ACWTAO775 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWTAO775 route product structure diagram
    ACWTAO77541355-18-4
Inquiry

Comments (0)